Authority: National Company Law Appellate Tribunal Principal Bench, New Delhi
Order Date: 16 October 2026
Case Overview
The National Company Law Appellate Tribunal (NCLAT) heard an application (I.A. No.4837 of 2026) filed by Ebix Singapore Pvt. Ltd. & Anr. (Appellants) seeking condonation of 71 days delay in refiling their appeal against State Bank of India (Sole Respondent). The appellants explained that the delay occurred due to circumstances beyond their control, specifically that Appellant No.2 was diagnosed with oral cancer and underwent multiple investigations during the period when defects needed to be removed from the filing. The defects were initially raised by the Registry in June 2026, and the appellant cited summer vacation at NCLAT and the medical condition of Appellant No.2 as reasons for the delay. The respondent (State Bank of India) opposed the application, arguing that the delay had not been sufficiently explained.
The Tribunal reviewed medical investigation reports submitted by the appellants which prima facie indicated that Appellant No.2 was diagnosed with malignancy and was undergoing treatment during the relevant period. The Tribunal accepted the defense that Appellant No.2's physical and mental disturbance due to cancer treatment prevented timely removal of the defects indicated by the Registry.
Final Outcome
The NCLAT allowed the application for condonation of delay, finding that the 71-day delay in refiling had been adequately explained. The delay was condoned and I.A. No.4837 of 2026 was disposed of.
In the main appeal (Company Appeal (AT) (Ins.) No. 1270 of 2026), the Tribunal found the matter requires consideration and issued notice to State Bank of India. The respondent was granted two weeks to file a reply, with the appellant given one week thereafter to file a rejoinder. The appeal was listed for next hearing on November 30, 2026 under the caption 'For admission (after notice)'.
Topics: Legal Proceedings, Banking Sector